Andrew D. Bowser

Highlighted: Chronic kidney disease and stroke risk, syphilis in ESRD patients, and how healthy diets may reduce CKD incidence.

Three new studies on ADPKD treatment project long-term impact of tolvaptan; reveal potential in an existing drug class; and, report success in slowing comorbid hepatic disease. 

Most children with ADPKD remain asymptomatic, but some manifest early and aggressive disease. Try our 6 questions on the new expert guidance on tricky treatment issues.

Autosomal dominant polycystic kidney disease is the most common form of polycystic renal disease. Find out what you know about ADPKD with this 7-question quiz on epidemiology, diagnosis, and more. 

The primary care role in detection, management, and reducing the risk of progression of CKD continues to expand. Test yourself here on basics in each category.

Keeping a loop diuretic on board during dialysis could be an effective, low-cost option to help improve patient outcomes, according to a new study.

How much do you know about HCV treatment in children and teens? Take this short, 5-question quiz to find out.

Study summaries highlight increased infection rates in young adults; a spike in HCV in reproductive-aged women; and a potential new treatment for HCV in young children.

ICYMI: HCV elimination success, SVR in blacks, transplant delisting, clearance after acute infection-catch up with a quiz.

Can DAA therapy remove patients from transplant waiting lists? Are HCV-infected livers--and hearts--safe for uninfected organ recipients? Three new studies explain.

Renowned transplant expert Gregory T. Everson, MD, talked with Patient Care about sensitive issues surrounding liver transplant in the era of direct-acting antiviral therapy.

Sample: Which type of practitioner most often makes the diagnosis of HCV: Gastro? GP? Hepatologist? Other?

Patient Care talked with Dr Kwo about recent updates to hepatitis C management guidelines, challenges in expanding screening, and more.

HCV screening rates improved at one large clinic from 24% to over 90% and were sustained at 1 year. How? With this 6-step intervention.

The newest HCV guidance is out on special populations. Are you up to date? Take our short, 5-question quiz to find out. 

For patients infected with hepatitis C virus who do not respond to direct-acting antiviral agents, results of a new study could mean a much brighter future.

Two new international studies on HCV show elimination programs have high levels of engagement, treatment initiation, and cure rates. 

These 5 questions on HCV infection are a quick brush-up on disease basics and treatment.

Who gets the cardioprotective agents? Are newer agents affordable? And, how low should A1c go? 

HCV screening of baby boomers seen in a suburban emergency department found remarkably high seropositivity rates, say authors of a new study. 

The current study was one of the largest analyses to date of black participants receiving all-oral DAA treatment.

Talking to your patients about cost of care can be difficult, but these five strategies are sure to help. 

How would you manage a patient with dementia and agitation? Take our 4-question case challenge from the 2018 ACP Internal Medicine Meeting to find out. 

This new quiz on hepatitis C tests what you know about mother-to-child transmission, testing at-risk populations, optimal regimens for your sickest patients, and more.

RA can be managed in primary care but comes with unique challenges. Here, strategies outlined at the ACP Internal Medicine Meeting 2018.

Five tips for PCPs on managing treatment-resistant depression were offered at the ACP Internal Medicine Meeting 2018 today. Patient Care offers a summary.

The recently-approved HCV treatment produced SVR rates of 95% or greater and discontinuation rates for AEs were  extremely low.

Black and Hispanic boomers had lower odds of HCV screening between 2013-2015, as did female and older members of the 1945-1965 cohort.